Case study shows intra-articular voriconazole successfully clears fungal PJI in a patient, suggesting new treatment options.
Prosthetic joint infection (PJI) is a high‐cost and high‐morbidity complication of total joint arthroplasty accounting for about 1%–2% of all joint replacements. Rarely, a fungal pathogen may cause coinfection or superinfection and complicate treatment. Fungal PJI is associated with higher morbidity and a lower rate of clearance of infection, with rates as low as 50% or less in the literature. Intra‐articular antibiotics as a treatment for PJI may be a promising intervention for challenging PJIs. We present a novel case utilizing voriconazole via intra‐articular catheters with successful clearance of a recalcitrant fungal prosthetic joint infection with 2 years' follow‐up. A detailed case study and protocol is presented for a 71‐year‐old male patient who failed two 2‐stage revision arthroplasties for complicated and recalcitrant fungal PJI. The patient was indicated for intra‐articular administration of antifungal medication. A two‐stage, both‐component knee revision with placement of two indwelling intra‐articular catheters was performed. Subsequently, voriconazole was administered daily for 6 weeks in alternating catheters. After completion of antifungal treatment, the catheters were removed in clinic. The patient demonstrates no evidence of infection after 2 years with a return to baseline function. To our knowledge, this is the first case in which intra‐articular voriconazole is administered through indwelling catheters of the knee. We demonstrate successful clearance of a complex and recalcitrant fungal PJI using this novel treatment. Intra‐articular use of voriconazole may be an option for patients with fungal PJI.
No takes yet. Share an insight, caveat, or question.
Hnatow et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: